Cargando…
国产血源性人凝血因子Ⅸ治疗血友病B的多中心Ⅲ期临床研究
OBJECTIVE: To evaluate the efficacy and safety of a domestic human plasma derived coagulation Factor Ⅸ concentrate (pd-FⅨ) in patients with hemophilia B. METHODS: The study was a multicenter, open-label and single-arm study. The efficacy of pd-F Ⅸ was evaluated by objective performance criteria. The...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342889/ https://www.ncbi.nlm.nih.gov/pubmed/29779350 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.05.011 |
Ejemplares similares
-
血友病A患儿凝血因子Ⅷ抑制物相关临床研究
Publicado: (2020) -
长效重组凝血因子Ⅸ药物治疗血友病B研究进展
Publicado: (2022) -
国产甲磺酸伊马替尼治疗慢性髓性白血病慢性期早期疗效和安全性的前瞻性、多中心临床研究
Publicado: (2015) -
两种重组人凝血因子Ⅷ制剂在血友病A患者中的群体药代动力学研究
por: Chelle, Pierre, et al.
Publicado: (2019) -
单中心22例获得性血友病的回顾性临床研究
Publicado: (2015)